Low Dose Aspirin Studied With the AggreGuide

Edward R. Teitel, M.D.13 enrolled

Overview

This study is to determine whether the AggreGuide platelet aggregometer can discern the effect of low dose aspirin on subjects platelet aggregation using arachidonic acid as the agonist.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Platelet Aggregation

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * adults Exclusion Criteria: * aspirin contraindications * anticoagulants * aspirin past week

Locations (1)

Aggredyne, Inc.

Houston, Texas, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.